Literature DB >> 3530303

Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.

W Kirch, J Stenzel, P Dylewicz, H J Hutt, S R Santos, E E Ohnhaus.   

Abstract

In a placebo controlled double-blind study including 10 patients with heart failure the nisoldipine/digoxin interaction was studied. Nisoldipine was shown to elevate digoxin plasma concentrations significantly by about 15% (trough levels). During chronic combination therapy with nisoldipine trough levels and plasma concentrations 4 h after the morning dose of digoxin were 1.35 +/- 0.14 and 1.92 +/- 0.16 ng ml-1 respectively, whereas they averaged to 1.16 +/- 0.14 and 1.52 +/- 0.16 ng ml-1 with digoxin and placebo (P less than 0.05; mean +/- s.e. mean). Systolic time intervals were significantly altered by nisoldipine co-administration compared with digoxin plus placebo. In certain patients the elevation of digoxin plasma levels due to nisoldipine co-administration could be of clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530303      PMCID: PMC1401112          DOI: 10.1111/j.1365-2125.1986.tb05243.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Systolic time intervals in heart failure in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Circulation       Date:  1968-02       Impact factor: 29.690

2.  The effect of nifedipine on serum digoxin concentrations in patients.

Authors:  J B Schwartz; A Raizner; S Akers
Journal:  Am Heart J       Date:  1984-04       Impact factor: 4.749

3.  Interaction between digoxin and calcium antagonists and antiarrhythmic drugs.

Authors:  G G Belz; W Doering; R Munkes; J Matthews
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

4.  Pharmacodynamics of a single dose of quinidine during chronic digoxin treatment. A randomized double blind placebo and sparteine--controlled crossover study.

Authors:  G G Belz; P E Aust; W Doering; M Heinz; B Schneider
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).

Authors:  S Kazda; B Garthoff; H Meyer; K Schlossmann; K Stoepel; R Towart; W Vater; E Wehinger
Journal:  Arzneimittelforschung       Date:  1980

6.  [Antianginal effect of calcium antagonists, using nisoldipine as an example].

Authors:  O M Hess; H P Krayenbühl
Journal:  Schweiz Med Wochenschr       Date:  1984-08-18

7.  Influence of verapamil on the inotropism and pharmacokinetics of digoxin.

Authors:  K E Pedersen; P Thayssen; N A Klitgaard; B D Christiansen; F Nielsen-Kudsk
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency.

Authors:  W Kirch; E E Ohnhaus; P Dylewicz; J Pabst; L Storstein
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

9.  Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects.

Authors:  H C Stern; J H Matthews; G G Belz
Journal:  Br Heart J       Date:  1984-10

10.  Effect of nifedipine on digoxin kinetics in healthy subjects.

Authors:  K E Pedersen; A Dorph-Pedersen; S Hvidt; N A Klitgaard; K Kjaer; F Nielsen-Kudsk
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

View more
  12 in total

1.  Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).

Authors:  Mitsuo Saito; Mutsuko Hirata-Koizumi; Shinji Miyake; Ryuichi Hasegawa
Journal:  Eur J Clin Pharmacol       Date:  2005-07-23       Impact factor: 2.953

Review 2.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 4.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 5.  Clinical pharmacokinetics of calcium antagonists. An update.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

6.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 7.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 8.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

9.  Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals.

Authors:  W Kirch; C Logemann; H Heidemann; S R Santos; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  The interaction of the calcium antagonist RO 40-5967 with digoxin.

Authors:  M Siepmann; C Kleinbloesem; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.